Winum JY - Search Results

1

Are tumour-associated carbonic anhydrases genuine therapeutic targets for photodynamic therapy?

Merabti A, Richeter S, Supuran CT, Clement S, Winum JY. Merabti A, et al. Among authors: winum jy. Expert Opin Ther Targets. 2023 Jul-Dec;27(9):817-826. doi: 10.1080/14728222.2023.2255380. Epub 2023 Sep 13. Expert Opin Ther Targets. 2023. PMID: 37668158 Review.

2

N-(tert-butoxycarbonyl)-N-[4-(dimethylazaniumylidene)-1,4-dihydropyridin-1-ylsulfonyl]azanide: a new sulfamyolating agent. Structure and reactivity toward amines.

Winum JY, Toupet L, Barragan V, Dewynter G, Montero JL. Winum JY, et al. Org Lett. 2001 Jul 12;3(14):2241-3. doi: 10.1021/ol0161312. Org Lett. 2001. PMID: 11440589

3

Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression.

Passagne I, Evrard A, Winum JY, Depeille P, Cuq P, Montero JL, Cupissol D, Vian L. Passagne I, et al. Among authors: winum jy. J Pharmacol Exp Ther. 2003 Nov;307(2):816-23. doi: 10.1124/jpet.103.051938. Epub 2003 Sep 11. J Pharmacol Exp Ther. 2003. PMID: 12970393

4

Inclusion complexes of 2-chloroethylnitrososulfamides (CENS) with beta-cyclodextrin.

Kadri M, Dhaoui N, Abdaoui M, Winum JY, Montero JL. Kadri M, et al. Among authors: winum jy. Eur J Med Chem. 2004 Jan;39(1):79-84. doi: 10.1016/j.ejmech.2003.11.003. Eur J Med Chem. 2004. PMID: 14987836

5

Kinetic investigation on aqueous decomposition of 2-chloroethylnitrososulfamide.

Seridi A, Kadri M, Abdaoui M, Winum JY, Montero JL. Seridi A, et al. Among authors: winum jy. Bioorg Med Chem Lett. 2006 Feb 15;16(4):1021-7. doi: 10.1016/j.bmcl.2005.10.080. Epub 2005 Nov 10. Bioorg Med Chem Lett. 2006. PMID: 16289822

6

Inclusion complexes of N-sulfamoyloxazolidinones with beta-cyclodextrin.

Kadri M, Djemil R, Abdaoui M, Winum JY, Coutrot F, Montero JL. Kadri M, et al. Among authors: winum jy. Bioorg Med Chem Lett. 2005 Feb 15;15(4):889-94. doi: 10.1016/j.bmcl.2004.12.060. Bioorg Med Chem Lett. 2005. PMID: 15686881

7

Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta isoforms of the human thromboxane receptor.

Hanson J, Reynaud D, Qiao N, Devel P, Moray AL, Renard JF, Kelley LP, Winum JY, Montero JL, Kinsella BT, Pirotte B, Pace-Asciak CR, Dogné JM. Hanson J, et al. Among authors: winum jy. J Med Chem. 2006 Jun 15;49(12):3701-9. doi: 10.1021/jm060108a. J Med Chem. 2006. PMID: 16759113

8

Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors.

Julémont F, de Leval X, Michaux C, Renard JF, Winum JY, Montero JL, Damas J, Dogné JM, Pirotte B. Julémont F, et al. Among authors: winum jy. J Med Chem. 2004 Dec 30;47(27):6749-59. doi: 10.1021/jm049480l. J Med Chem. 2004. PMID: 15615524

9

Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives.

Casini A, Winum JY, Montero JL, Scozzafava A, Supuran CT. Casini A, et al. Among authors: winum jy. Bioorg Med Chem Lett. 2003 Mar 10;13(5):837-40. doi: 10.1016/s0960-894x(03)00028-3. Bioorg Med Chem Lett. 2003. PMID: 12617903

10

Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.

Winum JY, Vullo D, Casini A, Montero JL, Scozzafava A, Supuran CT. Winum JY, et al. J Med Chem. 2003 May 22;46(11):2197-204. doi: 10.1021/jm021124k. J Med Chem. 2003. PMID: 12747791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page